IMCC IM Cannabis Corporation

-0.019 (-2.84%)
Last Updated: 11:33:46
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 10,705
Bid Price 0.6395
Ask Price 0.65
News -
Day High 0.67


52 Week Range


Day Low 0.6395
Company Name Stock Ticker Symbol Market Type
IM Cannabis Corporation IMCC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.019 -2.84% 0.65 11:33:46
Open Price Low Price High Price Close Price Prev Close
0.6697 0.6395 0.67 0.669
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
72 10,705 $ 0.6635656 $ 7,103 - 0.511 - 4.925
Last Trade Time Type Quantity Stock Price Currency
11:33:46 100 $ 0.65 USD

IM Cannabis Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
8.7M 13.39M - 82.51M -188.89M -14.11 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

IM Cannabis News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No IMCC Message Board. Create One! See More Posts on IMCC Message Board See More Message Board Posts

Historical IMCC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.65520.6990.5110.61080480,058-0.0052-0.79%
1 Month0.741.070.5110.7642591150,230-0.09-12.16%
3 Months0.97041.150.5110.798985668,031-0.3204-33.02%
6 Months0.731.430.5110.900529962,486-0.08-10.96%
1 Year3.8694.9250.5112.0797,190-3.22-83.2%
3 Years86.50116.300.51121.24200,236-85.85-99.25%
5 Years86.50116.300.51121.24200,236-85.85-99.25%

IM Cannabis Description

IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany.